Skip to main content
. 2016 Apr 14;98(5):818–829. doi: 10.1016/j.ajhg.2016.03.003

Table 1.

The Whole Genomes of Nine Highly Aggressive, Treatment-Naive Primary Prostate Tumors and One Nodal Metastasis Were Sequenced

Sample Gleason Score Age at Diagnosis PSA at Diagnosis (ng/dL) Germline Cov. Tumor Cov. Est. Purity (%)a Est. Ploidy
MC-1T 9 60 5.1 52.1 101.5 49 2.14
MC-2T 8 68 7.1 48.1 87.5 51 1.96
MC-3T 9 54 17.5 48.4 98.5 56 2.1
MC-4T 9 77 17.7 50.5 97.7 50 2.15
MC-5T 9 62 4.4 52.2 100.3 79 2.08
MC-6T 10 76 15.2 46.9 103.5 50 2.19
MC-7T 9 56 7.93 45.5 96.2 62 2.22
MC-8T 9 66 11.14 48.2 82.5 59 2.25
MC-9T 8 54 7.68 45.7 92.2 75 1.96
MC-10M 7b 63 22.3 45.1 93.1 75 2.51
MEAN 63.6 11.6 48.3 95.3 60.6 2.2

Additional clinical information and sequencing metrics can be found in Tables S1 and S2. Purity and ploidy were estimated with Patchwork.24

a

All tumors were macrodissected to target at least 70% Gleason grade 4+ cytoarchitecture, and the purity estimate reported here is the actual purity calculated from sequencing data.

b

For MC-10M, the Gleason score refers to the primary tumor, while the sequenced DNA was isolated from a nodal metastasis.